IE32708L - 3 - amino - 4 - halogenosydnonimines - Google Patents
3 - amino - 4 - halogenosydnoniminesInfo
- Publication number
- IE32708L IE32708L IE690400A IE40069A IE32708L IE 32708 L IE32708 L IE 32708L IE 690400 A IE690400 A IE 690400A IE 40069 A IE40069 A IE 40069A IE 32708 L IE32708 L IE 32708L
- Authority
- IE
- Ireland
- Prior art keywords
- heterocyclic ring
- substituted
- cycloalkyl
- march
- halogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/04—1,2,3-Oxadiazoles; Hydrogenated 1,2,3-oxadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
1,219,254. Sydnonimine derivatives. BOEHRINGER INGELHEIM G.m.b.H. 26 March, 1969 [26 March, 1968], No. 15910/69. Heading C2C Compounds of the general formula (R 1 , 2 = alkyl, cycloalkyl, aralkyl optionally substituted by CH 3 or halogen, heterocyclic ring linked via alkylene chain to N, or -NR 1 R 2 = heterocyclic ring optionally containing more than one heteroatom and/or being substituted by CH 3 ; R 3 = H, -COR 4 (R4 = alkyl, cycloalkyl, Ph, halophenyl, alkoxy, unsubstituted or substituted nitrogen-containing heterocyclic ring); Hal = halogen) and their acid addition salts are prepared by halogenating a compound of the formula or an acid addition salt thereof, optionally followed by deacylation and/or salt formation. The preparation of the starting materials by standard methods is described. The above compounds are hypotensive agents, and the salts may be administered in the form of pharmaceutical preparations containing them in association with a carrier.
[GB1219254A]
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19681770061 DE1770061A1 (en) | 1968-03-26 | 1968-03-26 | New substituted 3-amino-4-bromosydnomimines |
Publications (2)
Publication Number | Publication Date |
---|---|
IE32708L true IE32708L (en) | 1969-09-26 |
IE32708B1 IE32708B1 (en) | 1973-10-31 |
Family
ID=5700383
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IE400/69A IE32708B1 (en) | 1968-03-26 | 1969-03-25 | Sydnonimine derivatives |
Country Status (18)
Country | Link |
---|---|
AT (1) | AT285619B (en) |
BE (1) | BE730510A (en) |
BG (1) | BG15220A3 (en) |
BR (1) | BR6907417D0 (en) |
CA (1) | CA945990A (en) |
CH (1) | CH519511A (en) |
DE (1) | DE1770061A1 (en) |
DK (1) | DK130296B (en) |
ES (2) | ES364979A1 (en) |
FI (1) | FI54480C (en) |
FR (1) | FR2004770A1 (en) |
GB (1) | GB1219254A (en) |
HU (1) | HU162735B (en) |
IE (1) | IE32708B1 (en) |
IL (1) | IL31909A (en) |
NL (1) | NL6904632A (en) |
SE (1) | SE374746B (en) |
YU (1) | YU69369A (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2930736A1 (en) | 1979-07-28 | 1981-02-12 | Cassella Ag | PHARMACOLOGICALLY ACTIVE, SUBSTITUTED 3-AMINO-SYDNONIMINE, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE |
-
1968
- 1968-03-26 DE DE19681770061 patent/DE1770061A1/en active Pending
-
1969
- 1969-03-04 FI FI644/69A patent/FI54480C/en active
- 1969-03-18 CH CH409069A patent/CH519511A/en not_active IP Right Cessation
- 1969-03-20 ES ES364979A patent/ES364979A1/en not_active Expired
- 1969-03-21 BR BR207417/69A patent/BR6907417D0/en unknown
- 1969-03-21 YU YU00693/69A patent/YU69369A/en unknown
- 1969-03-25 AT AT293569A patent/AT285619B/en not_active IP Right Cessation
- 1969-03-25 DK DK165269AA patent/DK130296B/en unknown
- 1969-03-25 HU HUBO1177A patent/HU162735B/hu unknown
- 1969-03-25 IE IE400/69A patent/IE32708B1/en unknown
- 1969-03-25 SE SE6904193A patent/SE374746B/xx unknown
- 1969-03-25 BG BG011905A patent/BG15220A3/en unknown
- 1969-03-26 CA CA046,827A patent/CA945990A/en not_active Expired
- 1969-03-26 FR FR6908875A patent/FR2004770A1/fr active Pending
- 1969-03-26 GB GB05910/69A patent/GB1219254A/en not_active Expired
- 1969-03-26 NL NL6904632A patent/NL6904632A/xx not_active Application Discontinuation
- 1969-03-26 IL IL31909A patent/IL31909A/en unknown
- 1969-03-26 BE BE730510D patent/BE730510A/xx unknown
-
1970
- 1970-02-27 ES ES376981A patent/ES376981A1/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
NL6904632A (en) | 1969-09-30 |
GB1219254A (en) | 1971-01-13 |
DK130296B (en) | 1975-02-03 |
CH519511A (en) | 1972-02-29 |
DE1770061A1 (en) | 1971-09-16 |
IL31909A (en) | 1973-01-30 |
CA945990A (en) | 1974-04-23 |
HU162735B (en) | 1973-04-28 |
BR6907417D0 (en) | 1973-04-12 |
FI54480B (en) | 1978-08-31 |
IE32708B1 (en) | 1973-10-31 |
YU69369A (en) | 1978-09-18 |
FR2004770A1 (en) | 1969-11-28 |
SE374746B (en) | 1975-03-17 |
DK130296C (en) | 1975-06-30 |
ES364979A1 (en) | 1971-02-16 |
AT285619B (en) | 1970-11-10 |
IL31909A0 (en) | 1969-05-28 |
ES376981A1 (en) | 1972-05-01 |
BE730510A (en) | 1969-09-26 |
BG15220A3 (en) | 1975-11-21 |
FI54480C (en) | 1978-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1409693A (en) | Triazolobenzodiazepines | |
GB1432576A (en) | Substituted phenylacetic acids | |
GB1418822A (en) | Imidazo-and pyrimido-2,1-b-quinazolin-2-ones and a process for the preparation thereof | |
IE36947L (en) | 14 - dihydropyridinecarboxycic acid esters | |
IE43312L (en) | Propanolamine derivatives | |
GB1147379A (en) | 4-alkyl-dialkoxy-ª‡-methylphenethylamines and pharmacologically acceptable salts | |
ES368973A1 (en) | Derivatives of (benzimidazolyl-2-methyl) piperazine and their process of preparation | |
GB1456627A (en) | Pyridobenzodiazepinones | |
GB1367785A (en) | 2-substituted adenosine derivatives and the production thereof | |
GB1394568A (en) | Diazepine derivatives and process for the production thereof | |
GB1434805A (en) | 5-phenoxy-4-amino pyrimidines | |
GB1443692A (en) | 1,2-diphenylethanolamine derivatives and their salts and the preparation thereof | |
IE32708B1 (en) | Sydnonimine derivatives | |
GB1292410A (en) | Thienobenzothiazepine derivatives | |
GB1206088A (en) | New pyrazolodiazepinone compounds and methods for their production | |
GB1449426A (en) | Phenoxyalkylamine derivatives and preparation therof | |
GB1290381A (en) | ||
GB1208195A (en) | Process for producing benzodiazepine derivatives | |
GB1345214A (en) | Isoxazoles | |
GB1412932A (en) | Pharmaceutically active leurosine derivatives and preparation thereof | |
IE32946B1 (en) | Phenethylamine derivatives and process for the manufacture thereof | |
GB1468079A (en) | Ethanolamine derivatives | |
GB1254270A (en) | Benzoxazepine derivatives | |
GB1384523A (en) | Oxime derivatives and their preparation | |
IE39401B1 (en) | New adrenergic blocking aminopropanols |